{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:55:22Z","timestamp":1794099322528,"version":"4.8.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25594-0","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:54:41Z","timestamp":1763988881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of clinical pharmacy services in patients receiving antithrombotic treatment in a randomized controlled trial"],"prefix":"10.1038","volume":"15","author":[{"given":"Damla","family":"Sosyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-9957","authenticated-orcid":false,"given":"Muhammed Yunus","family":"Bektay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusret","family":"Acikgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5568-7012","authenticated-orcid":false,"given":"Fikret Vehbi","family":"Izzettin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"25594_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.101622","author":"O Gaidai","year":"2023","unstructured":"Gaidai, O., Cao, Y. & Loginov, S. Global cardiovascular diseases death rate prediction. Curr. Probl. Cardiol. (2023). https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101622","journal-title":"Curr. Probl. Cardiol."},{"key":"25594_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.15511\/tjtfp.18.00253","volume":"9","author":"H D\u00fclek","year":"2018","unstructured":"D\u00fclek, H., Tuzcular Vural, Z. & G\u00f6nen\u00e7, I. Risk factors in cardiovascular diseases. J. Turkish Family Physician. 9, 53\u201358. https:\/\/doi.org\/10.15511\/tjtfp.18.00253 (2018).","journal-title":"J. Turkish Family Physician"},{"key":"25594_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5543\/tkda.2017.47034","volume":"45","author":"Z \u00d6ngen","year":"2017","unstructured":"\u00d6ngen, Z. Anticoagulation therapy and the use of non-vitamin K antagonist oral anticoagulants in the elderly. Turk. Kardiyoloji Dernegi Arsivi. 45, 86\u201388. https:\/\/doi.org\/10.5543\/tkda.2017.47034 (2017).","journal-title":"Turk. Kardiyoloji Dernegi Arsivi"},{"key":"25594_CR4","unstructured":"Amaraneni, A., Chippa, V., Goldin, J. & Rettew, A. C. Anticoagulation Safety. (StatPearls Publishing, 2024). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519025\/. Accessed 3 Oct 2025."},{"key":"25594_CR5","unstructured":"Heart, stroke and vascular disease: Australian facts, Atrial fibrillation\u2014Australian Institute of Health and Welfare [Internet]. [cited 2025 Oct 3]. (2025). https:\/\/www.aihw.gov.au\/reports\/heart-stroke-vascular-diseases\/hsvd-facts\/contents\/all-heart-stroke-and-vascular-disease\/atrial-fibrillation. Accessed 3."},{"key":"25594_CR6","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/S00228-019-02752-8","volume":"75","author":"A Frazer","year":"2019","unstructured":"Frazer, A. et al. Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients. Eur. J. Clin. Pharmacol. 75, 1645\u20131657. https:\/\/doi.org\/10.1007\/S00228-019-02752-8 (2019).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"25594_CR7","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1111\/jth.14253","volume":"16","author":"G Palareti","year":"2018","unstructured":"Palareti, G. et al. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism. J. Thromb. Haemost. 16, 1994\u20132002. https:\/\/doi.org\/10.1111\/jth.14253 (2018).","journal-title":"J. Thromb. Haemost"},{"key":"25594_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.thromres.2019.01.020","volume":"175","author":"D Little","year":"2019","unstructured":"Little, D. et al. Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis. Thromb. Res. 175, 102\u2013109. https:\/\/doi.org\/10.1016\/j.thromres.2019.01.020 (2019).","journal-title":"Thromb. Res."},{"key":"25594_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/S11940-017-0438-5","author":"JA Stone","year":"2017","unstructured":"Stone, J. A. et al. Therapies for hemorrhagic transformation in acute ischemic stroke. Curr. Treat. Options Neurol. https:\/\/doi.org\/10.1007\/S11940-017-0438-5 (2017).","journal-title":"Curr. Treat. Options Neurol"},{"key":"25594_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0270263","author":"JC Wung","year":"2022","unstructured":"Wung, J. C. et al. Drug-related problem characterization and the solved status associated factor analysis in a pharmacist-managed anticoagulation clinic. PLoS One https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0270263 (2022).","journal-title":"PLoS One"},{"key":"25594_CR11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s11096-018-0696-7","volume":"40","author":"N Griese-Mammen","year":"2018","unstructured":"Griese-Mammen, N. et al. PCNE definition of medication review: reaching agreement. Int. J. Clin. Pharm. Neth. 40, 1199\u20131208. https:\/\/doi.org\/10.1007\/s11096-018-0696-7 (2018).","journal-title":"Int. J. Clin. Pharm. Neth."},{"key":"25594_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2165\/00002018-200022040-00005","volume":"22","author":"PMLA Van Den Bemt","year":"2000","unstructured":"Van Den Bemt, P. M. L. A., Egberts, T. C. G., De Jong-Van Den Berg, L. T. W. & Brouwers, J. R. B. J. Drug-related problems in hospitalised patients. Drug Saf. 22, 321\u2013333. https:\/\/doi.org\/10.2165\/00002018-200022040-00005 (2000).","journal-title":"Drug Saf."},{"key":"25594_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2020.531038","volume":"8","author":"MF Rasool","year":"2020","unstructured":"Rasool, M. F. et al. Risk factors associated with medication errors among patients suffering from chronic disorders. Front. Public. Health. 8, 1\u20137. https:\/\/doi.org\/10.3389\/fpubh.2020.531038 (2020).","journal-title":"Front. Public. Health"},{"key":"25594_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/20420986211027451","author":"C Paradissis","year":"2021","unstructured":"Paradissis, C. et al. Patient harm from cardiovascular medications. Ther. Adv. Drug Saf. https:\/\/doi.org\/10.1177\/20420986211027451 (2021).","journal-title":"Ther. Adv. Drug Saf."},{"key":"25594_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/EHJQCCO\/QCAE045","volume":"10","author":"B Kefale","year":"2024","unstructured":"Kefale, B., Peterson, G. M., Mirkazemi, C. & Bezabhe, W. M. The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis. Eur. Heart J. Qual. Care Clin. Outcomes. 10, 488\u2013506. https:\/\/doi.org\/10.1093\/EHJQCCO\/QCAE045 (2024).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"25594_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-020-05346-8","volume":"20","author":"G Lin","year":"2020","unstructured":"Lin, G. et al. Clinical and economic outcomes of hospital pharmaceutical care: A systematic review and meta-analysis. BMC Health Serv. Res. 20, 1\u201314. https:\/\/doi.org\/10.1186\/s12913-020-05346-8 (2020).","journal-title":"BMC Health Serv. Res."},{"key":"25594_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/JCPT.13633","volume":"47","author":"A El-Awaisi","year":"2022","unstructured":"El-Awaisi, A., Al-Shaibi, S., Al-Ansari, R., Naseralallah, L. & Awaisu, A. A systematic review on the impact of pharmacist-provided services on patients\u2019 health outcomes in Arab countries. J. Clin. Pharm. Ther. 47, 879\u2013896. https:\/\/doi.org\/10.1111\/JCPT.13633 (2022).","journal-title":"J. Clin. Pharm. Ther."},{"key":"25594_CR18","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/archinte.166.9.955","volume":"166","author":"PJ Kaboli","year":"2006","unstructured":"Kaboli, P. J., Hoth, A. B., McClimon, B. J. & Schnipper, J. L. Clinical pharmacists and inpatient medical care: A systematic review. Arch. Intern. Med. 166, 955\u2013964. https:\/\/doi.org\/10.1001\/archinte.166.9.955 (2006).","journal-title":"Arch. Intern. Med."},{"key":"25594_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/HEALTHCARE10112315","author":"S Al-Qahtani","year":"2022","unstructured":"Al-Qahtani, S., Jalal, Z., Paudyal, V., Mahmood, S. & Mason, J. The role of pharmacists in providing pharmaceutical care in primary and secondary prevention of stroke: A systematic review and meta-analysis. Healthcare (Switzerland)  https:\/\/doi.org\/10.3390\/HEALTHCARE10112315 (2022).","journal-title":"Healthcare (Switzerland)"},{"key":"25594_CR20","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2015.09.025","volume":"66","author":"SP Dunn","year":"2015","unstructured":"Dunn, S. P. et al. The role of the clinical pharmacist in the care of patients with cardiovascular disease. J. Am. Coll. Cardiol.. 66, 2129\u20132139. https:\/\/doi.org\/10.1016\/j.jacc.2015.09.025 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"25594_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/BMJ.C332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz, K. F., Altman, D. G. & Moher, D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ 340, 698\u2013702. https:\/\/doi.org\/10.1136\/BMJ.C332 (2010).","journal-title":"BMJ"},{"key":"25594_CR22","first-page":"90","volume":"6","author":"C van Walraven","year":"2012","unstructured":"van Walraven, C., Wong, J. & Forster, A. J. LACE\u2009+\u2009index: extension of a validated index to predict early death or urgent readmission after hospital discharge using administrative data. Open. Med. 6, 90\u2013100 (2012).","journal-title":"Open. Med."},{"key":"25594_CR23","doi-asserted-by":"publisher","first-page":"1049289","DOI":"10.3389\/fphar.2022.1049289","volume":"13","author":"MY Bektay","year":"2022","unstructured":"Bektay, M. Y., Sancar, M., Okyaltirik, F., Durdu, B. & Izzettin, F. V. Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial. Front. Pharmacol. Switz. 13, 1049289. https:\/\/doi.org\/10.3389\/fphar.2022.1049289 (2022).","journal-title":"Front. Pharmacol. Switz."},{"key":"25594_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.5530\/jyp.2018.10.100","volume":"10","author":"M Greeshma","year":"2018","unstructured":"Greeshma, M., Lincy, S., Maheswari, E., Tharanath, S. & Viswam, S. Identification of drug related problems by clinical pharmacist in prescriptions with polypharmacy: A prospective interventional study. J. Young Pharmacists. 10, 460\u2013465. https:\/\/doi.org\/10.5530\/jyp.2018.10.100 (2018).","journal-title":"J. Young Pharmacists"},{"key":"25594_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(10)61188-9","volume":"377","author":"V Patel","year":"2011","unstructured":"Patel, V. et al. Chronic diseases and injuries in India. Lancet 377, 413\u2013428. https:\/\/doi.org\/10.1016\/S0140-6736(10)61188-9 (2011).","journal-title":"Lancet"},{"key":"25594_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.18553\/jmcp.2017.23.5.520","volume":"23","author":"SC Weddle","year":"2017","unstructured":"Weddle, S. C. et al. Assessment of clinical pharmacy interventions to reduce outpatient use of high-risk medications in the elderly. J. Manag Care Spec. Pharm. 23, 520\u2013524. https:\/\/doi.org\/10.18553\/jmcp.2017.23.5.520 (2017).","journal-title":"J. Manag Care Spec. Pharm."},{"key":"25594_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/CIA.S201039","volume":"14","author":"E Ertuna","year":"2019","unstructured":"Ertuna, E. et al. Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in turkey: A retrospective study. Clin. Interv Aging. 14, 587\u2013600. https:\/\/doi.org\/10.2147\/CIA.S201039 (2019).","journal-title":"Clin. Interv Aging"},{"key":"25594_CR28","doi-asserted-by":"publisher","first-page":"S312","DOI":"10.5530\/ijper.55.1s.64","volume":"55","author":"MY Bektay","year":"2021","unstructured":"Bektay, M. Y., Gokce, M., Selvitop, R., Bolat, E. & Yildiz, G. B. Investigation of the effects of polypharmacy on cognitive functions: cohort study. Indian J. Pharm. Educ. Res. 55, S312\u2013S317. https:\/\/doi.org\/10.5530\/ijper.55.1s.64 (2021).","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"25594_CR29","first-page":"76","volume":"12","author":"A Nukala","year":"2021","unstructured":"Nukala, A., Vanga, H., Keerthi, T. & Kandukuri, K. A comprehensive analysis of impact of past medications on current admission in a tertiary care hospital: A prospective observational study. J. Basic. Clin. Pharm. 12, 76\u201381 (2021).","journal-title":"J. Basic. Clin. Pharm."},{"key":"25594_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0206120","volume":"13","author":"YL Niriayo","year":"2018","unstructured":"Niriayo, Y. L., Kumela, K., Kassa, T. D. & Angamo, M. T. Drug therapy problems and contributing factors in the management of heart failure patients in Jimma university specialized Hospital, Southwest Ethiopia. PLoS One. 13, 1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0206120 (2018).","journal-title":"PLoS One"},{"key":"25594_CR31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.clinthera.2020.02.005","volume":"42","author":"AI Pl\u00e1cido","year":"2020","unstructured":"Pl\u00e1cido, A. I., Herdeiro, M. T., Morgado, M., Figueiras, A. & Roque, F. Drug-related problems in Home-dwelling older adults: A systematic review. Clin. Ther. 42, 559\u2013572e14. https:\/\/doi.org\/10.1016\/j.clinthera.2020.02.005 (2020).","journal-title":"Clin. Ther."},{"key":"25594_CR32","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/bcp.14709","volume":"87","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Impact of pharmacist-led medication therapy management in ambulatory elderly patients with chronic diseases. Br. J. Clin. Pharmacol. 87, 2937\u20132944. https:\/\/doi.org\/10.1111\/bcp.14709 (2021).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"25594_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-022-07494-5","volume":"22","author":"A Albayrak","year":"2022","unstructured":"Albayrak, A., Ba\u015fgut, B., B\u0131kmaz, G. A. & Karahalil, B. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital. BMC Health Serv. Res. BioMed. Cent. 22, 1\u20137. https:\/\/doi.org\/10.1186\/s12913-022-07494-5 (2022).","journal-title":"BMC Health Serv. Res. BioMed. Cent."},{"key":"25594_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2753.2010.01375.x","volume":"17","author":"RL Castelino","year":"2011","unstructured":"Castelino, R. L., Bajorek, B. V. & Chen, T. F. Are interventions recommended by pharmacists during home medicines review evidence-based? J. Eval Clin. Pract. 17, 104\u2013110. https:\/\/doi.org\/10.1111\/j.1365-2753.2010.01375.x (2011).","journal-title":"J. Eval Clin. Pract."},{"key":"25594_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11096-015-0199-8","volume":"38","author":"SH Chau","year":"2016","unstructured":"Chau, S. H. et al. Clinical medication reviews in elderly patients with polypharmacy: A cross-sectional study on drug-related problems in the Netherlands. Int. J. Clin. Pharm. 38, 46\u201353. https:\/\/doi.org\/10.1007\/s11096-015-0199-8 (2016).","journal-title":"Int. J. Clin. Pharm."},{"key":"25594_CR36","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1111\/bcp.13640","volume":"84","author":"H Kari","year":"2018","unstructured":"Kari, H., Kortej\u00e4rvi, H., Airaksinen, M. & Laaksonen, R. Patient involvement is essential in identifying drug-related problems. Br. J. Clin. Pharmacol. 84, 2048\u20132058. https:\/\/doi.org\/10.1111\/bcp.13640 (2018).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"25594_CR37","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1331\/JAPhA.2012.10163","volume":"52","author":"SNS Leikola","year":"2012","unstructured":"Leikola, S. N. S., Virolainen, J., Tuomainen, L., Tuominen, R. K. & Airaksinen, M. S. A. Comprehensive medication reviews for elderly patients: Findings and recommendations to physicians. J. Am. Pharm. Assoc.. 52, 630\u2013633. https:\/\/doi.org\/10.1331\/JAPhA.2012.10163 (2012).","journal-title":"J. Am. Pharm. Assoc."},{"key":"25594_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1331\/JAPhA.2012.12036","volume":"52","author":"DR Touchette","year":"2012","unstructured":"Touchette, D. R. et al. Safety-focused medication therapy management: A randomized controlled trial. J. Am. Pharm. Assoc. 52, 603\u2013612. https:\/\/doi.org\/10.1331\/JAPhA.2012.12036 (2012).","journal-title":"J. Am. Pharm. Assoc."},{"key":"25594_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2165\/11586850-000000000-00000","volume":"28","author":"HF Kwint","year":"2011","unstructured":"Kwint, H. F., Faber, A., Gussekloo, J. & Bouvy, M. L. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: A pragmatic randomized controlled study. Drugs Aging. 28, 305\u2013314. https:\/\/doi.org\/10.2165\/11586850-000000000-00000 (2011).","journal-title":"Drugs Aging"},{"key":"25594_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2710.2012.01370.x","volume":"37","author":"HF Kwint","year":"2012","unstructured":"Kwint, H. F., Faber, A., Gussekloo, J. & Bouvy, M. L. The contribution of patient interviews to the identification of drug-related problems in home medication review. J. Clin. Pharm. Ther. 37, 674\u2013680. https:\/\/doi.org\/10.1111\/j.1365-2710.2012.01370.x (2012).","journal-title":"J. Clin. Pharm. Ther."},{"key":"25594_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jfma.2012.04.013","volume":"113","author":"DC Chan","year":"2014","unstructured":"Chan, D. C., Chen, J. H., Wen, C. J., Chiu, L. S. & Wu, S. C. Effectiveness of the medication safety review clinics for older adults prescribed multiple medications. J. Formos. Med. Assoc. 113, 106\u2013113. https:\/\/doi.org\/10.1016\/j.jfma.2012.04.013 (2014).","journal-title":"J. Formos. Med. Assoc."},{"key":"25594_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11096-017-0571-y","volume":"40","author":"M Rhalimi","year":"2018","unstructured":"Rhalimi, M., Rauss, A. & Housieaux, E. Drug-related problems identified during geriatric medication review in the community pharmacy. Int. J. Clin. Pharm. 40, 109\u2013118. https:\/\/doi.org\/10.1007\/s11096-017-0571-y (2018).","journal-title":"Int. J. Clin. Pharm."},{"key":"25594_CR43","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/jep.12737","volume":"23","author":"SV Kova\u010devi\u0107","year":"2017","unstructured":"Kova\u010devi\u0107, S. V. et al. Evaluation of drug-related problems in older polypharmacy primary care patients. J. Eval Clin. Pract. 23, 860\u2013865. https:\/\/doi.org\/10.1111\/jep.12737 (2017).","journal-title":"J. Eval Clin. Pract."},{"key":"25594_CR44","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1345\/aph.1E640","volume":"39","author":"KM O\u2019Dell","year":"2005","unstructured":"O\u2019Dell, K. M. & Kucukarslan, S. N. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome. Ann. Pharmacother. 39, 1423\u20131427. https:\/\/doi.org\/10.1345\/aph.1E640 (2005).","journal-title":"Ann. Pharmacother."},{"key":"25594_CR45","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.5603\/KP.a2016.0136","volume":"74","author":"D Swieczkowski","year":"2016","unstructured":"Swieczkowski, D., Merks, P., Gruchala, M. & Jaguszewski, M. J. The role of the pharmacist in the care of patients with cardiovascular diseases. Kardiol Pol. Pol. 74, 1319\u20131326. https:\/\/doi.org\/10.5603\/KP.a2016.0136 (2016).","journal-title":"Kardiol Pol. Pol."},{"key":"25594_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hsr2.786","volume":"5","author":"M Amankwa Harrison","year":"2022","unstructured":"Amankwa Harrison, M. et al. Drug-related problems among hospitalized hypertensive and heart failure patients and physician acceptance of pharmacists\u2019 interventions at a teaching hospital in Ghana. Health Sci. Rep. 5, 1\u201310. https:\/\/doi.org\/10.1002\/hsr2.786 (2022).","journal-title":"Health Sci. Rep."},{"key":"25594_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40886-016-0050-5","volume":"2","author":"F Acheampong","year":"2016","unstructured":"Acheampong, F., Nkansah, F. A. & Anto, B. P. Drug-related problems and their clinical interventions in a Ghanaian teaching hospital. Saf. Health Saf. Health. 2, 1\u20137. https:\/\/doi.org\/10.1186\/s40886-016-0050-5 (2016).","journal-title":"Saf. Health Saf. Health"},{"key":"25594_CR48","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s00508-020-01801-y","volume":"133","author":"M Stuhec","year":"2021","unstructured":"Stuhec, M., Flegar, I., Zelko, E., Kova\u010di\u010d, A. & Zabavnik, V. Clinical pharmacist interventions in cardiovascular disease pharmacotherapy in elderly patients on excessive polypharmacy: A retrospective pre-post observational multicentric study. Wien Klin. Wochenschr. 133, 770\u2013779. https:\/\/doi.org\/10.1007\/s00508-020-01801-y (2021).","journal-title":"Wien Klin. Wochenschr"},{"key":"25594_CR49","first-page":"70","volume":"2","author":"J Shareef","year":"2014","unstructured":"Shareef, J., Sandeep, B. & Shastry, C. S. Assessment of drug related problems in patients with cardiovascular diseases in a tertiary care teaching hospital. J. Pharm. Care. 2, 70\u201376 (2014).","journal-title":"J. Pharm. Care"},{"key":"25594_CR50","doi-asserted-by":"publisher","first-page":"A53 LP","DOI":"10.1136\/ejhpharm-2018-eahpconf.118","volume":"25","author":"T Laranjeira","year":"2018","unstructured":"Laranjeira, T., Mirco, A. & Falc\u00e3o, F. 4CPS-027\u2005Hospital pharmacist interventions in an accredited cardiology department. Eur. J. Hosp. Pharm. 25, A53 LP\u2013A54 https:\/\/doi.org\/10.1136\/ejhpharm-2018-eahpconf.118 (2018).","journal-title":"Eur. J. Hosp. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25594-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:54:43Z","timestamp":1763988883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25594-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25594"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25594-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study received ethical approval from the Clinical Research Ethics Committee (Decision No: 19\/5), and written informed consent was obtained from all participants. All procedures adhered to the ethical standards of the University of Siena and the principles of the 1964 Helsinki Declaration and its later amendments. This study protocol has been registered on 05\/01\/2024 at ClinicalTrials.gov (NCT06193473).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"41692"}}